Detalhe da pesquisa
1.
The alpha-adrenoceptor control of adrenocorticotropin secretion in man.
J Clin Endocrinol Metab
; 49(2): 227-30, 1979 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255
2.
Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist, on prolactin secretion stimulated by insulin-induced hypoglycemia.
J Clin Endocrinol Metab
; 47(3): 671-4, 1978 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-45467
3.
Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
J Clin Endocrinol Metab
; 45(3): 588-93, 1977 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-302840
4.
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
J Clin Endocrinol Metab
; 80(11): 3267-72, 1995 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-7593436
5.
Hormonal mechanism of milk secretion in the newborn.
J Clin Endocrinol Metab
; 44(5): 973-6, 1977 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-404310
6.
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
J Clin Endocrinol Metab
; 76(2): 484-8, 1993 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-8432794
7.
Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
J Clin Endocrinol Metab
; 63(1): 266-8, 1986 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-3711262
8.
Sandostatin LAR in acromegalic patients: long-term treatment.
J Clin Endocrinol Metab
; 82(1): 23-8, 1997 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8989226
9.
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
J Clin Endocrinol Metab
; 86(6): 2779-86, 2001 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-11397887
10.
Sandostatin LAR in acromegalic patients: a dose-range study.
J Clin Endocrinol Metab
; 80(12): 3601-7, 1995 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8530606
11.
A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments.
J Clin Endocrinol Metab
; 48(1): 9-12, 1979 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-422709
12.
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
J Clin Endocrinol Metab
; 75(1): 275-80, 1992 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-1619019
13.
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
J Clin Endocrinol Metab
; 85(9): 3132-40, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10999798
14.
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment.
Eur J Endocrinol
; 143(3): 353-61, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-11022177
15.
New evidence for growth hormone modulation by the alpha-adrenergic system in man.
Metabolism
; 26(11): 1225-30, 1977 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551
16.
Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships.
Metabolism
; 45(8 Suppl 1): 27-30, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8769375
17.
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients.
Metabolism
; 45(8 Suppl 1): 67-71, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8769387
18.
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
Fertil Steril
; 59(5): 980-7, 1993 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8486199
19.
A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
Fertil Steril
; 57(1): 74-80, 1992 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-1730334
20.
Return of gonadotropic function in postpartum women during bromocriptine treatment.
Fertil Steril
; 51(4): 622-7, 1989 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2494080